McLeod Ian has filed 13 insider transactions across 1 company since March 2026.
Most recent transaction: a grant/award of 13097 shares of Anika Therapeutics, Inc. ($ANIK) on March 19, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 19, 2026 | Anika Therapeutics, Inc. | $ANIK | McLeod Ian | SVP, CAO & Treasurer | A | Restricted Stock Unit | 13097 | $0.00 | 13,097.0000 | 14,419,000 | 9999.99% | 0.09% |
| March 19, 2026 | Anika Therapeutics, Inc. | $ANIK | McLeod Ian | SVP, CAO & Treasurer | A | Restricted Stock Unit | 11194 | $0.00 | 11,194.0000 | 14,419,000 | 9999.99% | 0.08% |
| March 19, 2026 | Anika Therapeutics, Inc. | $ANIK | McLeod Ian | SVP, CAO & Treasurer | A | Premium Priced Stock Appreciation Rights | 17663 | $0.00 | 17,663.0000 | 14,419,000 | 9999.99% | 0.12% |
| March 15, 2026 | Anika Therapeutics, Inc. | $ANIK | McLeod Ian | SVP, CAO & Treasurer | M | Common Stock | 2658 | $0.00 | 24,888.0000 | 14,419,000 | 11.96% | 0.02% |
| March 15, 2026 | Anika Therapeutics, Inc. | $ANIK | McLeod Ian | SVP, CAO & Treasurer | F | Common Stock | 781 | $14.20 | 24,107.0000 | 14,419,000 | 3.14% | 0.01% |
| March 14, 2026 | Anika Therapeutics, Inc. | $ANIK | McLeod Ian | SVP, CAO & Treasurer | M | Restricted Stock Unit | 3774 | $0.00 | 7,550.0000 | 14,419,000 | 33.33% | 0.03% |
| March 15, 2026 | Anika Therapeutics, Inc. | $ANIK | McLeod Ian | SVP, CAO & Treasurer | M | Restricted Stock Unit | 2658 | $0.00 | 2,659.0000 | 14,419,000 | 49.99% | 0.02% |
| March 14, 2026 | Anika Therapeutics, Inc. | $ANIK | McLeod Ian | SVP, CAO & Treasurer | M | Common Stock | 3774 | $0.00 | 22,518.0000 | 14,419,000 | 20.13% | 0.03% |
| March 14, 2026 | Anika Therapeutics, Inc. | $ANIK | McLeod Ian | SVP, CAO & Treasurer | A | Common Stock | 1161 | $0.00 | 23,679.0000 | 14,419,000 | 5.16% | 0.01% |
| March 14, 2026 | Anika Therapeutics, Inc. | $ANIK | McLeod Ian | SVP, CAO & Treasurer | F | Common Stock | 1449 | $14.20 | 22,230.0000 | 14,419,000 | 6.12% | 0.01% |
| March 9, 2026 | Anika Therapeutics, Inc. | $ANIK | McLeod Ian | SVP, CAO & Treasurer | M | Common Stock | 2197 | $0.00 | 19,383.0000 | 14,419,000 | 12.78% | 0.02% |
| March 9, 2026 | Anika Therapeutics, Inc. | $ANIK | McLeod Ian | SVP, CAO & Treasurer | F | Common Stock | 639 | $14.96 | 18,744.0000 | 14,419,000 | 3.30% | 0.00% |
| March 9, 2026 | Anika Therapeutics, Inc. | $ANIK | McLeod Ian | SVP, CAO & Treasurer | M | Restricted Stock Unit | 2197 | $0.00 | 0.0000 | 14,419,000 | 100.00% | 0.02% |